Review Article Neonatal Abstinence Syndrome Karen McQueen, R.N., Ph.D., and Jodie Murphy-Oikonen, M.S.W., Ph.D. N Engl J Med Volume 375(25):2468-2479 December 22, 2016
Summary Infants born to mothers who take opioids may have symptoms of opioid withdrawal after birth. Early detection and holistic treatment that incorporates pharmacologic and nonpharmacologic interventions can help improve outcomes for affected infants.
Clinical and Other Consequences of Maternal Opioid Use. McQueen K, Murphy-Oikonen J. N Engl J Med 2016;375:2468-2479
Clinical Manifestations and Outcomes of the Neonatal Abstinence Syndrome. McQueen K, Murphy-Oikonen J. N Engl J Med 2016;375:2468-2479
Biologic Testing in the Neonate. McQueen K, Murphy-Oikonen J. N Engl J Med 2016;375:2468-2479
Assessment Tools to Guide Pharmacologic Treatment of the Neonatal Abstinence Syndrome. McQueen K, Murphy-Oikonen J. N Engl J Med 2016;375:2468-2479
A Standardized Treatment Protocol for the Neonatal Abstinence Syndrome. McQueen K, Murphy-Oikonen J. N Engl J Med 2016;375:2468-2479